Oakstone Addiction Medicine for Non-Specialists 2025 (Videos + Slides PDFs)

Overview

Oakstone Addiction Medicine for Non-Specialists 2025 (Videos + Slides PDFs) is a comprehensive on-demand video program designed for clinicians who manage patients with substance use disorders, regardless of whether substance use is their primary complaint. This collection provides thorough and practical lectures to support improved screening, treatment, referral, and follow-up care for patients affected by addiction.

On-demand addiction medicine education — accessible anytime, anywhere.

Format: Videos and slides PDFs
Date of Original Release: April 30, 2025
Date Credits Expire: April 29, 2028

Agenda

This program includes expert lectures covering a wide range of topics pertinent to addiction medicine practice.

• Addiction – An Overview — Antoine Douaihy, MD
• Neurobiological Aspects of Substance Use Disorder — Jody Glance, MD
• The Epidemiology of Substance Use Disorders — Antoine Douaihy, MD
• Screening, Evaluation, and Diagnosis of Substance Use Disorders — Antoine Douaihy, MD
• The Pharmacology of Substances of Use — Sharon Connor, MD, and Cassandra Kruse, MD
• Management of Intoxication, Withdrawal, and Perioperative Care in Individuals with Substance Use Disorders — Megha Patel, PharmD, BCPS
• Alcohol Use Disorder — Julie Kmiec, DO
• Stimulant Use Disorder (StUD) – Treatment Overview and Future Therapies — Thersilla Oberbarnscheidt, MD, PhD
• Opioid Use Disorder — Julie Kmiec, DO
• Benzodiazepine Use and Misuse — Tae Woo Park, MD
• Cannabis Use Disorder — Thersilla Oberbarnscheidt, MD
• Tobacco Use Disorder — Antoine Douaihy, MD
• Chronic Pain and Substance Use Disorders — Amanda Price, MD
• Acute Pain and Substance Use Disorder — Julie Wilson Childers, MD
• Brief Interventions and Motivational Interviewing for Substance Use Disorders — Cassandra Boness, PhD
• Helping Patients with Substance Use Disorders and Co-occurring Psychiatric Disorders (CODs) — Dennis Daley, PhD
• The Use of Harm Reduction Strategies with Substance Use Disorders — David Loveland, PhD
• Perinatal Substance Use Disorders — Jody Glance, MD
• Pharmacotherapy for Adolescents with Substance Use Disorders — Duncan Clark, MD, PhD
• Substance Use Disorders in Older Individuals — Katie F. Jones, MD
• Healthcare and Racial Disparities in Addiction Treatment — Antoine Douaihy, MD
• Medical Complications of Substance Use Disorders including HIV and HCV — Jordi Blanch, MD, PhD
• Pain and Opioid Complexity in Individuals with Serious Illness — Varad Deshmukh, MD
• The Rise of Gambling Disorder – Significance, Assessment, and Treatment in an Era of Exploding Access — Kavita Fischer, MD
• Technology Addiction — Hector Colon-Rivera, MD
• Helping Family Members Affected by Substance Use Disorders — Dennis Daley, PhD
• Mindfulness-based Treatment of Substance Use Disorders — Antoine Douaihy, MD
• Safe and Efficacious Prescribing for Chronic Pain — James R. Latronica, DO, DFASAM

Speakers

This program features presentations by experienced practitioners and researchers in addiction medicine, pharmacology, psychiatry, and related fields. Their collective expertise addresses clinical care, neurobiology, epidemiology, and health disparities in substance use disorders.

Target Audience

This program is intended for non-specialist clinicians, including primary care providers, psychiatrists, psychologists, nurse practitioners, physician assistants, and other healthcare professionals involved in the care of patients with substance use disorders.

Why This Topic Matters

Oakstone Addiction Medicine for Non-Specialists 2025 (Videos + Slides PDFs) equips clinicians with essential knowledge to better understand and manage substance use disorders within diverse patient populations. Addiction medicine remains a complex and evolving field, requiring ongoing education to apply evidence-based approaches effectively.

Delivered through MedHub Central, this program promotes improved clinical confidence and competence in addiction medicine. It supports professionals in addressing the multifaceted nature of addiction, including pharmacology, comorbidities, and social determinants affecting treatment outcomes.